Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 258,243 | 202,008 | 192,842 | 0 | 0 |
| Operating Income | -258,243 | -202,008 | -192,842 | N/A | N/A |
| Interest Expense | 0 | 0 | 3,358 | 0 | 0 |
| Other Income | -58,138 | 17,083 | -15,422 | 0 | 0 |
| Pre-tax Income | -316,381 | -184,925 | -211,622 | 0 | 0 |
| Income Tax | N/A | -331 | -117 | 0 | N/A |
| Net Income Continuous | -316,381 | -184,594 | -211,505 | N/A | N/A |
| Net Income | $-316,381 | $-184,594 | $-211,505 | $0 | $N/A |
| EPS Basic Total Ops | -2.63 | -1.83 | -7.31 | N/A | N/A |
| EPS Basic Continuous Ops | -2.63 | -1.83 | -7.31 | N/A | N/A |
| EPS Diluted Total Ops | -2.63 | -1.83 | -7.31 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.63 | -1.83 | -7.31 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.08 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-247,407 | $-200,577 | $-192,378 | $N/A | $N/A |